ArticleDrugs in R&D2026

HIF-1α siRNA Enhances the Efficacy of Erlotinib in Non-small Cell Lung Cancer: A Novel Strategy to Reverse Hypoxia-Induced Drug Resistance.

Haojie Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.